Inflammation, adiponectin, obesity and cardiovascular risk

Area of Science:

• Cardiovascular Science
• Immunology
• Metabolic Syndrome Research

Background:

• Atherosclerosis involves chronic immune-mediated inflammation, particularly in metabolic syndrome.
• Adipokines, chemokines, and cytokines are crucial in atherosclerosis initiation and progression.
• Metabolic risk factors like obesity and insulin resistance promote vascular inflammation.

Purpose of the Study:

• To review the impact of adiponectin, cytokines (Neopterin), adipose tissue distribution, and drug effects on atherosclerosis.
• To highlight the role of immune mediators in cardiovascular disease pathogenesis.

Main Methods:

• Review of scientific literature on atherosclerosis, metabolic syndrome, and immune factors.
• Analysis of the roles of specific adipokines, cytokines, and adipose tissue characteristics.
• Examination of pleiotropic drug effects on disease course.

Main Results:

• Adiponectin, monocyte/T-cell cytokines (Neopterin), and adipose tissue distribution significantly influence atherosclerosis.
• Chronic vascular inflammation is a key feature driven by metabolic risk factors.
• Pleiotropic drug effects can modulate the individual course of atherosclerosis.

Conclusions:

• Immune and metabolic factors intricately regulate atherosclerosis development and progression.
• Targeting specific inflammatory pathways and metabolic risk factors is crucial for cardiovascular disease prevention.
• Personalized approaches considering adipose tissue and drug effects are important for managing atherosclerosis.